Controlled natural cycle IVF: A novel approach for a dominant follicle durin an in-vitro maturation cycle

Reproductive BioMedicine Online

Volumn 14, Issue 5, 2007, Pages 598-601

  Kadoch, Isaac Jacques ^a,b,c   Fanchin, Renato ^a   Frydman, Nelly ^a   Le Du, Anne ^a   Frydman, René ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b UNIVERSITY OF MONTREAL   (Canada)

^c OVO Fertility Clinic   (Canada)

Author keywords

Human oocyte; In vitro maturation; Metformin; Natural cycle IVF; Polycystic ovarian syndrome

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; METFORMIN; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; NIDATION; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; PREGNANCY; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY;

EID: 34248634295     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1472-6483(10)61052-8     Document Type: Article

References (21)

1. Chian RC, Buckett WM, Tan SL 2004 In-vitro maturation of oocytes. Reproductive BioMedicine Online 8, 148-166.
2. Cobo AC, Requena A, Neuspiller F et al. 1999 Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size. Human Reproduction. 14, 1864-1868.
3. Daya S, Gunby J, Hughes EG et al. 1995 Natural cycles for in-vitro fertilization cost effectiveness analysis and factors influencing outcome. Human Reproduction 10, 1719-1724.
4. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800.
5. Fauser BC, Van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 18, 71-106.
6. Franks S 1995 Polycystic ovary syndrome. New England Journal of Medicine 333, 853-861.
7. Franks S, Gilling-Smith C, Watson H et al. 1999 Insulin action in the normal and polycystic ovary. Endocrinology and Metabolism Clinics of North America 28, 361-378.
8. Gore MA, Nayudu PL, Vlaisavljevic V 1997 Attending dominance in vivo: distinguishing dominant from challenger follicles in humans. Human Reproduction 12, 2741-2747.
9. Kettel LM, Roseff SJ, Chiu TC et al. 1991 Follicular arrest during the midfollicular phase of the menstrual cycle; a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. Journal of Clinical Endocrinology and Metabolism 73, 644-649.
10. Le Du A, Kadoch IJ, Bourcigaux N et al. 2005 In-vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Human Reproduction 20, 420-424.
11. Macklon NS, Fauser BC 2000 Regulation of follicle development and novel approaches to ovarian stimulation for IVF. Human Reproduction Update 6, 307-312.
12. Mikkelsen AL, Lindenberg S 2001 Influence of the dominant follicle on in-vitro maturation of human oocytes: a prospective non-randomized study. Reproductive BioMedicine Online 3, 199-204.
13. Nargund G, Waterstone J, Bland J et al. 2001 Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Human Reproduction 16, 259-262.
14. Nestler JE, Clore JN, Blackard WG 1989 The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 161, 1095-1097.
15. Phillips SJ, Kadoch IJ, Lapensee L et al. 2007 Controlled natural cycle IVF: our experience in a world of stimulation. Reproductive BioMedicine Online 14, 356-359.
16. Rongières-Bertrand C, Olivennes F, Righini C et al. 1999 Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Human Reproduction 14, 683-688.
17. Siebert TI, Kruger TF, Steyn DW, Nosarka S 2006 Is the addition of metformin efficacious in the treatment of clomiphene citrate resistant patients with polycystic ovarian syndrome? A structured literature review. Fertility and Sterility 86, 1432-1437.
18. Stadtmauer LA, Toma SK, Riehl RM et al. 2002 Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization. Reproductive BioMedicine Online 5, 112-116.
19. Steptoe PC, Edwards RG 1978 Birth after the reimplantation of a human embryo. Lancet ii, 366.
20. Tan SL, Child TJ, Gulekli B 2002 In-vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. American Journal of Obstetrics and Gynecology 186, 684-689.
21. The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41-47.